The 2nd SAU Annual Conference on Urological Research

The Serican Academy of Urology (SAU), established in the fall of 2022, is an international non-profit organization dedicated to uniting clinicians and basic scientists to address diseases related to the genitourinary tract. Prostate cancer, particularly castration-resistant prostate cancer (CRPC), remains a significant public health issue. The second annual SAU conference was held from June 13-16, 2024, at Banff Rocky Mountain Resorts, Alberta, Canada. Sponsored by MedChemExpress, ABclonal, and NovinoPath, and chaired by Dr. Xiaoqi Liu, the conference focused on the latest research in urological diseases. Topics included epigenetic regulation, novel treatment targets, bioinformatics, cancer etiology, progression and metastasis, the tumor microenvironment and immunotherapy, and overcoming resistance to existing therapies. Keynote addresses by leading scientists Drs. Jindan Yu and Qianben Wang emphasized the complexity of epigenetic and transcriptional regulation in prostate cancer. The Women’s Forum provided a platform to discuss career navigation and leadership development for women scientists in a predominantly male field. The conference concluded with a banquet, including an awards ceremony and committee reports.

Authors

Institutions

Publication Details

Journal
Serican Journal of Medicine
Published
2024-12-06
DOI
https://doi.org/10.17161/sjm.v1i1.23103
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The 2nd SAU Annual Conference on Urological Research

Benyi Li, Xiaoqi Liu
Serican Journal of Medicine
Prostate Cancer Treatment and Research
article

The 2nd SAU Annual Conference on Urological Research

Benyi Li, Xiaoqi Liu
article en

Abstract

The Serican Academy of Urology (SAU), established in the fall of 2022, is an international non-profit organization dedicated to uniting clinicians and basic scientists to address diseases related to the genitourinary tract. Prostate cancer, particularly castration-resistant prostate cancer (CRPC), remains a significant public health issue. The second annual SAU conference was held from June 13-16, 2024, at Banff Rocky Mountain Resorts, Alberta, Canada. Sponsored by MedChemExpress, ABclonal, and NovinoPath, and chaired by Dr. Xiaoqi Liu, the conference focused on the latest research in urological diseases. Topics included epigenetic regulation, novel treatment targets, bioinformatics, cancer etiology, progression and metastasis, the tumor microenvironment and immunotherapy, and overcoming resistance to existing therapies. Keynote addresses by leading scientists Drs. Jindan Yu and Qianben Wang emphasized the complexity of epigenetic and transcriptional regulation in prostate cancer. The Women’s Forum provided a platform to discuss career navigation and leadership development for women scientists in a predominantly male field. The conference concluded with a banquet, including an awards ceremony and committee reports.

Serican Journal of MedicineVol. 1(1)
University of Kentucky (US)
Openalex Percentile: Top 56%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.